Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Research

20-CNR-568_CQD_650x450_482145647
February 3, 2020/Cancer/Research

New Approach Leads to Transfusion Independence in Low-risk MDS

Luspatercept shows promise for patients with few options

19-CNR-5095 NCI grant 650×450
January 29, 2020/Cancer/Research

NCI Grant to Cleveland Clinic Scientist Will Support Evolution-Based Cancer Research

Searching for new insights into drug resistance, collateral sensitivity

19-CNR-6810 QD ASH Top 10 Twitter
January 23, 2020/Cancer/Research

Top 10 Takeaways from ASH 2019

These research results will have impact in 2020

18-CCC-5885-DNA-PTA-test-650×450
January 15, 2020/Cancer/Research

New Clinic Tackles Mutations That Increase Risk of Blood Cancers and Heart Disease

CHIP Clinic's goals: Research, preventive care

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-invasive-lobular-breast-cancer
December 12, 2019/Cancer/Research

No Survival Advantage from Chemo-endocrine Therapy over Endocrine Therapy in Invasive Lobular Carcinoma

Study suggests limited role for CET in this cancer type

QD-Follicular-Lymphoma-WINTER
December 9, 2019/Cancer/Research

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Study assesses outcomes of therapies with novel agents

T-cells_650x450
December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

QD-Myelofibrosis-GERDS
December 9, 2019/Cancer/Research

Treatment for Myelofibrosis-Associated Anemia on the Horizon

Interim results of phase 2 trial are promising

AML
December 8, 2019/Cancer/Research

Studies’ Results Support Liberalization of Some Eligibility Criteria for Acute Myeloid Leukemia Clinical Trials

Overly restrictive exclusions may lead to racial disparities and unrealistic outcomes

650×450-Acute lymphoblastic-leukemia2
December 7, 2019/Cancer/Research

Pediatric-inspired Post-remission Chemotherapy Superior to Stem Cell Transplantation for Young Adults with ALL

Study results from ASH 2019 shed light on treatment

BackPage 16 of 31Next

Advertisement

Ad